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Exuberante de Dermatite de Contacto Alérgica ao 
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RESUMO – O L-Mesitran Tulle® é um penso não aderente de polietileno popular, impregnado com o gel L-Mesitran Soft patentea-
do que contém Medilan™, considerada uma "lanolina hipoalergénica". A lanolina é um alergénio bem conhecido e a prevalência 
de alergia de contato aos álcoois de lanolina varia de 0,6% a 6,9%. Relatamos o caso de um doente que desenvolveu eczema ao 
redor de úlcera da perna enquanto realizava cuidados de peno com o L-Mesitran Tulle®, destacando que mesmo essa "lanolina de 
grau médico de alta pureza" (Medilan™) contida no L-Mesitran Tulle® pode causar dermatite de contacto alérgica. 
PALAVRAS-CHAVE – Dermatite de Contacto Alérgica; Lanolina.
A Hard-to-Heal Cutaneous Ulcer: An Exuberant Case 
of Allergic Contact Dermatitis to L-Mesitran® Tulle  
ABSTRACT – L-Mesitran Tulle® is a popular non-adherent polyethylene dressing impregnated with the patented L-Mesitran Soft gel 
that contains Medilan™, which is said to be a “hypoallergenic lanolin”. Lanolin is a well know sensitizer and the prevalence of con-
tact allergy to lanolin alcohols varies from 0.6% - 6.9%. We report the case of a patient who develop eczema around the leg ulcer 
while using L-Mesitran Tulle® as a wound dressing, highlighting that even this “high purity medical grade of lanolin” (Medilan™) 
contained in L-Mesitran Tulle® can cause an allergic contact dermatitis. 
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INTRODUCTION
L-Mesitran Tulle® is a popular non-adherent polyethyle-
ne dressing impregnated with the patented L-Mesitran Soft 
gel, which main ingredients are 40% medical grade honey, 
propylene glycol, polyethylene glycol (PEG) 4000, vitamins 
C & E and Medilan™ - said to be a “medical grade hypoal-
lergenic lanolin”/“the high purity medical grade of lanolin”. 
The skin healing ability of honey has been attributed to its 
antimicrobial properties, its ability to modulate the skin’s im-
mune system and promote tissue repair.1
We report the case of a patient who developed ecze-
ma around the leg ulcer while using L-Mesitran Tulle® as a 
wound dressing, although other allergens might also have 
contributed to the dermatitis. 
CASE REPORT
A 52-year-old male, mechanical engineer, with no his-
tory of atopy and no chronic medication, presented with 2x2 
cm ulcer on the pre-tibial region of the right leg. There was 
no underlying arterial disease but this painless ulcer that 
developed after trauma did not heal for 6 months despi-
te several leg ulcer dressings, including L-Mesitran Tulle®. 
In the preceding 3 weeks he developed intensely itchy and 
exudative erythematous plaques, vesicles and some pustu-
les on the ipsilateral leg, suggestive of acute eczema, with 
distant papulo-vesiculous lesions on the upper limbs. Oral 
prednisolone (starting with 40 mg/day, with 5 mg reduction 
every 3 days) was used in association with local care with 
potassium permanganate patches (1: 10 000) and topical 
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fluticasone cream and the leg ulcer dressing was replaced 
by Acquacel-Ag®. 
Due to worsening of eczema on the leg, contact derma-
titis was suspected and patch testing were performed. The 
European Baseline series and a cosmetics/vehicles and a to-
pical medications series (Chemotechnique Diagnostics, Ve-
llinge, Sweden) as well as small fragments of leg dressings, 
namely L-Mesitran Tulle® and Acquacel-Ag® were applied 
with finn chambers on the upper back. A semi-open test was 
performed with Prontosan® "as is", that was applied on the 
back, and after drying was covered only by a tissue tape. 
Patches were removed on day (D)2 and readings perfor-
med on D3 and D7. Strong positive reactions were observed 
to lanolin wool 30% pet. (+++), amerchol L101 50% pet. 
(+++) and L-Mesitran tulle® "as is" (+++), chlorhexidine 
digluconate 0.5% water (+) and Prontosan® "as is" in a semi-
-open test (+++) (Fig. 1). Patch tests with propolis 10%, 
propylene glycol 5% pet., Acquacel-Ag® "as is" and other 
dressings gave negative results. Treatment with Acquacel-
-Ag® was continued with improvement of the ulcer and total 
resolution of the eczema, reinforcing that L-Mesitran Tulle® 
containing lanolin was the main driver of his allergic contact 
dermatitis (ACD). We could not entirely clarify the positive 
reaction to Prontosan®, used only recently as a short contact 
disinfectant before the ulcer dressing application. An irritant 
reaction could not be completely excluded although more 
than 20 controls tested also in a semi-open test were nega-
tive. A positive reaction to chlorhexidine (1,6-bis(4-chloro-
phenylbiguanido)hexane) might represent a cross-reaction 
to polyhexanide (polyhexamethylene biguanide), the other 
biguanide present in Prontosan®, but we could not test it as 
the patient did not collaborate in further testing. 
DISCUSSION
Lanolin is a highly complex and variable mixture of long 
chain esters, lanolin alcohols and lanolin acids, derived 
from wool wax, the secretion of sheep sebaceous glands 
(Latin: lana = wool).2
Contact allergy to lanolin began to attract attention in 
the 1950s, and at the end of the 20th century it has achie-
ved notoriety among the general public and non-derma-
tologists as a sensitizer.2 The exact sensitizing component 
of lanolin remains unknown; however, most scientists agree 
that the alcohol fraction is the culprit allergen,3,4 and wool 
alcohols 30% in petrolatum (pet.) has been included in the 
European standard series since 1969.2,3,5 
The prevalence of contact allergy to lanolin alcohols va-
ries from 0.6% - 6.9%.3,4,6 Several studies have reported that 
Amerchol™ L101, a blend of mineral oil and about 10% 
lanolin alcohols, gives a higher yield of positive patch tests 
than 30% wool alcohols.2 A recent retrospective observatio-
nal study from Copenhagen of consecutively patch tested 
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Figura 1 (a-b) - Patch test reading at day 3 showing strong positive reactions to lanolin wool 30% pet. (+++), amerchol L101 50% pet. (+++) 
and L-Mesitran tulle® "as is" (+++), as well as to chlorhexidine (1+) and to Protosan® as is in a semi-open test.
A B
69
Caso Clínico
dermatitis patients (n=9577) between 1 January 2004 and 
31 December 2015 showed an overall increasing preva-
lence of contact allergy to lanolin and agreed that inclusion 
of Amerchol™ L101 will increase the chance of detecting 
lanolin contact allergy.4 Uter et al7 have recently analysed 
data from the Information Network of Departments of Der-
matology (IVDK) in Germany and did not observe an in-
creasing trend of contact allergy to lanolin alcohol and/or 
Amerchol™ L101. In the beginning of the current year, Knijp 
J et al6 confirmed that using lanolin alcohol and Amerchol™ 
L101 is an effective combination of patch test preparations 
for diagnosing lanolin contact allergy and concluded that 
routinely testing with other lanolin derivatives may not be 
worthwhile, as it detects only a few additional patients. 
In our Department we have been testing both lanolin 
alchools and Amerchol L101 for more than 20 years, with 
a decreasing frequency of reactions in the last 10 years 
from 2.6% and 2.9% of positive reactions respectively to la-
nolin and Amerchol L101 in 2007/8 to 1.2% and 1.8% in 
2017/18. This may be related with a decreasing trend of 
ACD to topical drugs, as shown also in other departments.8
Additionally, studies suggest that contact allergy to topi-
cal medicaments becomes more common with advancing 
age and that the incidence of positive patch test reactions 
to wool alcohols increases in patients with leg ulcers, stasis 
dermatitis, and other contact allergies,3 as in our patient.
There are some suggestions that "purified lanolin" is not 
so sensitizing,9 but this case illustrates that even this "high 
purity medical grade of lanolin" (Medilan™) contained in L-
-Mesitran Tulle® can cause ACD. 
Conflitos de interesse: Os autores declaram a inexistência de 
conflitos de interesse na realização do presente trabalho. 
Fontes de financiamento: Não existiram fontes externas de 
financiamento para a realização deste artigo. 
Confidencialidade dos dados: Os autores declaram ter segui-
do os protocolos da sua instituição acerca da publicação dos 
dados de doentes.
Consentimento: Consentimento do tutor legal para publica-
ção obtido. 
Proveniência e revisão por pares: Não comissionado; revisão 
externa por pares.
Conflicts of interest: The authors have no conflicts of interest 
to declare. 
Financing support: This work has not received any contribution, 
grant or scholarship. 
Confidentiality of data: The authors declare that they have 
followed the protocols of their work center on the publication 
of data from patients.
Patient Consent: Consent for publication was obtained. 
Provenance and peer review: Not commissioned; externally 
peer reviewed 
 ORCID
Joana Calvão
https://orcid.org/0000-0002-1161-269X
Margarida Gonçalo
http://orcid.org/0000-0001-6842-1360 
REFERENCES
1. McLoone P, Oluwadun A, Warnock M, Fyfe L. Honey: a 
therapeutic agent for disorders of the skin. Cent Asian J 
Glob Heal. 2016;5:241. doi:10.5195/cajgh.2016.241
2. Wakelin SH, Smith H, White IR, Rycroft RJG, Mcfadden 
JP. A retrospective analysis of contact allergy to lanolin. 
Br J Dermatol. 2001;145:28-31. doi:10.1046/j.1365-
2133.2001.04277.x
3. Nguyen JC, Chesnut G, James WD, Saruk M. Allergic 
contact dermatitis caused by lanolin (wool) alcohol con-
tained in an emollient in three postsurgical patients. J 
Am Acad Dermatol. 2010;62:1064-5. doi:10.1016/j.
jaad.2009.10.020
4. Fransen M, Overgaard LEK, Johansen JD, Thyssen JP. 
Contact allergy to lanolin: temporal changes in preva-
lence and association with atopic dermatitis. Contact 
Dermatitis. 2018;78:70-5. doi:10.1111/cod.12872
5. Epstein E, Mateo S. The detection of lanolin allergy. 
JAMA Dermatol. 1972;106:678-81.
6. Knijp J, Bruynzeel DP, Rustemeyer T. Diagnosing lanolin 
contact allergy with lanolin alcohol and Amerchol L101. 
Contact Dermatitis. 2019;80:298-303. doi:10.1111/
cod.13210
7. Uter W, Schnuch A, Geier J. Contact sensitization to 
lanolin alcohols and Amerchol® L101 – analysis of 
IVDK data. Contact Dermatitis. 2018;78:355-71. 
doi:10.1111/cod.12907
8. Gilissen L, Goossens A. Frequency and trends of contact 
allergy to and iatrogenic contact dermatitis caused by 
topical drugs over a 25-year period. Contact Dermati-
tis. 2016;75:290-302. doi:10.1111/cod.12621
9. Stone L. Medilan: A hypoallergenic lanolin for emollient 
therapy. Br J Nurs. 2000;9:54-7. doi:10.12968/
bjon.2000.9.1.6415
Revista SPDV 78(1) 2020; Dermatite de contacto alérgica ao L-Mesitran Tulle® ; Joana Calvão, Ricardo Batista, Margarida Gonçalo.
